|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 578.90 USD | -0.49% |
|
-3.44% | +18.27% |
| Capitalization | 24.69B 21.09B 19.32B 18.27B 33.82B 2,363B 34B 230B 89.57B 1,121B 92.65B 90.71B 3,898B | P/E ratio 2026 * |
21.2x | P/E ratio 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise value | 20.65B 17.63B 16.16B 15.27B 28.28B 1,976B 28.43B 192B 74.89B 938B 77.47B 75.84B 3,259B | EV / Sales 2026 * |
6.31x | EV / Sales 2027 * | 5.21x |
| Free-Float |
53.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: United Therapeutics Corporation
Trading United Therapeutics Corporation
| 1 day | -0.43% | ||
| 1 week | -3.44% | ||
| Current month | +0.86% | ||
| 1 month | -0.24% | ||
| 3 months | +21.66% | ||
| 6 months | +24.65% | ||
| Current year | +18.27% |
| 1 week | 561.2 |  | 599 |
| 1 month | 560.16 | | 609.35 |
| Current year | 455.63 | | 609.35 |
| 1 year | 272.12 | | 609.35 |
| 3 years | 204.44 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 25/06/1996 | |
| President | 54 | 25/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 12/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 31/12/2001 |
| Chairman | 71 | 25/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 31/12/2001 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 2.87% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.49% | -3.44% | +87.05% | +168.77% | 24.69B | |
| +2.56% | +2.99% | +36.26% | +133.96% | 883B | |
| +2.74% | +2.52% | +55.13% | +44.33% | 540B | |
| +0.47% | +1.75% | +10.96% | +42.31% | 367B | |
| +1.33% | -1.00% | +20.39% | +10.73% | 328B | |
| +0.13% | +1.47% | +35.23% | +14.72% | 288B | |
| +0.78% | +1.00% | +29.63% | +26.28% | 283B | |
| +1.29% | +0.18% | +48.47% | -2.23% | 278B | |
| +0.91% | +2.12% | -31.78% | -48.50% | 206B | |
| +0.12% | +1.65% | +24.45% | +44.13% | 181B | |
| Average | +0.95% | +1.13% | +31.58% | +43.45% | 337.84B | |
| Weighted average by Cap. | +1.50% | +0.62% | +30.93% | +51.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.27B 2.79B 2.56B 2.42B 4.48B 313B 4.5B 30.46B 11.86B 148B 12.27B 12.01B 516B | 3.71B 3.17B 2.9B 2.74B 5.08B 355B 5.1B 34.54B 13.45B 168B 13.91B 13.62B 585B |
| Net income | 1.28B 1.09B 1B 947M 1.75B 122B 1.76B 11.92B 4.64B 58.11B 4.8B 4.7B 202B | 1.51B 1.29B 1.18B 1.12B 2.07B 144B 2.08B 14.05B 5.47B 68.51B 5.66B 5.54B 238B |
| Net Debt | -4.05B -3.46B -3.17B -2.99B -5.54B -387B -5.57B -37.7B -14.68B -184B -15.18B -14.87B -639B | -5.38B -4.6B -4.21B -3.98B -7.37B -515B -7.41B -50.15B -19.52B -244B -20.19B -19.77B -850B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/26 | 577.64 $ | -0.70% | 167,072 |
| 12/05/26 | 581.74 $ | +2.08% | 397,479 |
| 11/05/26 | 569.88 $ | +0.87% | 460,695 |
| 08/05/26 | 564.94 $ | -0.74% | 628,487 |
| 07/05/26 | 569.18 $ | -4.62% | 830,890 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition